Cargando…

Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial

BACKGROUND: The effect of awake prone positioning on intubation rates is not established. The aim of this trial was to investigate if a protocol for awake prone positioning reduces the rate of endotracheal intubation compared with standard care among patients with moderate to severe hypoxemic respir...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosén, Jacob, von Oelreich, Erik, Fors, Diddi, Jonsson Fagerlund, Malin, Taxbro, Knut, Skorup, Paul, Eby, Ludvig, Campoccia Jalde, Francesca, Johansson, Niclas, Bergström, Gustav, Frykholm, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200797/
https://www.ncbi.nlm.nih.gov/pubmed/34127046
http://dx.doi.org/10.1186/s13054-021-03602-9
_version_ 1783707685169922048
author Rosén, Jacob
von Oelreich, Erik
Fors, Diddi
Jonsson Fagerlund, Malin
Taxbro, Knut
Skorup, Paul
Eby, Ludvig
Campoccia Jalde, Francesca
Johansson, Niclas
Bergström, Gustav
Frykholm, Peter
author_facet Rosén, Jacob
von Oelreich, Erik
Fors, Diddi
Jonsson Fagerlund, Malin
Taxbro, Knut
Skorup, Paul
Eby, Ludvig
Campoccia Jalde, Francesca
Johansson, Niclas
Bergström, Gustav
Frykholm, Peter
author_sort Rosén, Jacob
collection PubMed
description BACKGROUND: The effect of awake prone positioning on intubation rates is not established. The aim of this trial was to investigate if a protocol for awake prone positioning reduces the rate of endotracheal intubation compared with standard care among patients with moderate to severe hypoxemic respiratory failure due to COVID-19. METHODS: We conducted a multicenter randomized clinical trial. Adult patients with confirmed COVID-19, high-flow nasal oxygen or noninvasive ventilation for respiratory support and a PaO(2)/FiO(2) ratio ≤ 20 kPa were randomly assigned to a protocol targeting 16 h prone positioning per day or standard care. The primary endpoint was intubation within 30 days. Secondary endpoints included duration of awake prone positioning, 30-day mortality, ventilator-free days, hospital and intensive care unit length of stay, use of noninvasive ventilation, organ support and adverse events. The trial was terminated early due to futility. RESULTS: Of 141 patients assessed for eligibility, 75 were randomized of whom 39 were allocated to the control group and 36 to the prone group. Within 30 days after enrollment, 13 patients (33%) were intubated in the control group versus 12 patients (33%) in the prone group (HR 1.01 (95% CI 0.46–2.21), P = 0.99). Median prone duration was 3.4 h [IQR 1.8–8.4] in the control group compared with 9.0 h per day [IQR 4.4–10.6] in the prone group (P = 0.014). Nine patients (23%) in the control group had pressure sores compared with two patients (6%) in the prone group (difference − 18% (95% CI − 2 to − 33%); P = 0.032). There were no other differences in secondary outcomes between groups. CONCLUSIONS: The implemented protocol for awake prone positioning increased duration of prone positioning, but did not reduce the rate of intubation in patients with hypoxemic respiratory failure due to COVID-19 compared to standard care. TRIAL REGISTRATION: ISRCTN54917435. Registered 15 June 2020 (https://doi.org/10.1186/ISRCTN54917435). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-021-03602-9.
format Online
Article
Text
id pubmed-8200797
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82007972021-06-15 Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial Rosén, Jacob von Oelreich, Erik Fors, Diddi Jonsson Fagerlund, Malin Taxbro, Knut Skorup, Paul Eby, Ludvig Campoccia Jalde, Francesca Johansson, Niclas Bergström, Gustav Frykholm, Peter Crit Care Research BACKGROUND: The effect of awake prone positioning on intubation rates is not established. The aim of this trial was to investigate if a protocol for awake prone positioning reduces the rate of endotracheal intubation compared with standard care among patients with moderate to severe hypoxemic respiratory failure due to COVID-19. METHODS: We conducted a multicenter randomized clinical trial. Adult patients with confirmed COVID-19, high-flow nasal oxygen or noninvasive ventilation for respiratory support and a PaO(2)/FiO(2) ratio ≤ 20 kPa were randomly assigned to a protocol targeting 16 h prone positioning per day or standard care. The primary endpoint was intubation within 30 days. Secondary endpoints included duration of awake prone positioning, 30-day mortality, ventilator-free days, hospital and intensive care unit length of stay, use of noninvasive ventilation, organ support and adverse events. The trial was terminated early due to futility. RESULTS: Of 141 patients assessed for eligibility, 75 were randomized of whom 39 were allocated to the control group and 36 to the prone group. Within 30 days after enrollment, 13 patients (33%) were intubated in the control group versus 12 patients (33%) in the prone group (HR 1.01 (95% CI 0.46–2.21), P = 0.99). Median prone duration was 3.4 h [IQR 1.8–8.4] in the control group compared with 9.0 h per day [IQR 4.4–10.6] in the prone group (P = 0.014). Nine patients (23%) in the control group had pressure sores compared with two patients (6%) in the prone group (difference − 18% (95% CI − 2 to − 33%); P = 0.032). There were no other differences in secondary outcomes between groups. CONCLUSIONS: The implemented protocol for awake prone positioning increased duration of prone positioning, but did not reduce the rate of intubation in patients with hypoxemic respiratory failure due to COVID-19 compared to standard care. TRIAL REGISTRATION: ISRCTN54917435. Registered 15 June 2020 (https://doi.org/10.1186/ISRCTN54917435). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-021-03602-9. BioMed Central 2021-06-14 /pmc/articles/PMC8200797/ /pubmed/34127046 http://dx.doi.org/10.1186/s13054-021-03602-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Rosén, Jacob
von Oelreich, Erik
Fors, Diddi
Jonsson Fagerlund, Malin
Taxbro, Knut
Skorup, Paul
Eby, Ludvig
Campoccia Jalde, Francesca
Johansson, Niclas
Bergström, Gustav
Frykholm, Peter
Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial
title Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial
title_full Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial
title_fullStr Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial
title_full_unstemmed Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial
title_short Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial
title_sort awake prone positioning in patients with hypoxemic respiratory failure due to covid-19: the proflo multicenter randomized clinical trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200797/
https://www.ncbi.nlm.nih.gov/pubmed/34127046
http://dx.doi.org/10.1186/s13054-021-03602-9
work_keys_str_mv AT rosenjacob awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial
AT vonoelreicherik awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial
AT forsdiddi awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial
AT jonssonfagerlundmalin awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial
AT taxbroknut awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial
AT skoruppaul awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial
AT ebyludvig awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial
AT campocciajaldefrancesca awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial
AT johanssonniclas awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial
AT bergstromgustav awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial
AT frykholmpeter awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial
AT awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial